Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$22,254
+$564 QoQ
Shares Held
142
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,491
of 1,603 holders
Holding Since
Sep 2020
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Canton Hathaway, LLC holds $4,383,166 across 9 Drug Manufacturers - General names. NVS ranks #9 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,075 | $1,796,837 | |
| 2 | LLY |
ELI LILLY & Co
|
873 | $1,047,102 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,898 | $757,893 | |
| 4 | ABBV |
AbbVie Inc.
|
1,326 | $333,674 | |
| 5 | AMGN |
Amgen Inc
|
515 | $186,491 | |
| 6 | PFE |
Pfizer Inc
|
4,654 | $112,068 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,445 | $83,260 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
345 | $43,587 |
All Filings in NVS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,254 | 142 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $21,690 | 142 | Shares | Sole | 2026-04-24 | |
| 2025-09-30 | $20,390 | 159 | Shares | Sole | 2025-10-23 | |
| 2020-09-30 | $107,047 | 1,231 | Shares | Sole | 2020-11-09 | |
| No filing history on record for this holder in this stock. | ||||||